Wells Fargo & Company Poly Pid Ltd. Transaction History

Wells Fargo & Company

  • $434 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
BUY
$5.52 - $8.42 $4,316 - $6,584
782 New
782 $4,000
Q4 2020

Feb 09, 2021
SELL
$8.89 - $13.5 $4,445 - $6,750
-500 Closed
0 $0
Q3 2020

Nov 05, 2020
BUY
$11.0 - $17.33 $5,500 - $8,665
500 New
500 $6,000

About PolyPid Ltd.

PYPD Quotes by TradingView
  • Ticker PYPD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 19,551,200
  • Market Cap $64.5M
  • Description
  • PolyPid Ltd., a late-stage biopharma company, develops, manufactures, and commercializes products based on polymer-lipid encapsulation matrix (PLEX) platform to address unmet medical needs. Its lead product candidate is D-PLEX100, which is in Phase III clinical trial for the prevention of sternal (bone) surgical site infections (SSIs), as well a...
More about PYPD
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email